STARD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.879200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.172600E-01
Normal-vs-Stage2
7.371000E-01
Normal-vs-Stage3
4.118200E-02
Normal-vs-Stage4
7.862600E-01
Stage1-vs-Stage2
5.457600E-01
Stage1-vs-Stage3
4.620100E-02
Stage1-vs-Stage4
8.468600E-01
Stage2-vs-Stage3
3.036300E-04
Stage2-vs-Stage4
4.875800E-01
Stage3-vs-Stage4
9.708300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.021600E-01
Normal-vs-AfricanAmerican
2.949800E-01
Normal-vs-Asian
7.889600E-01
Caucasian-vs-AfricanAmerican
6.529400E-01
Caucasian-vs-Asian
9.455400E-01
AfricanAmerican-vs-Asian
6.220600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.120400E-01
Normal-vs-Female
4.707600E-01
Male-vs-Female
3.108000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.304800E-01
Normal-vs-Age(41-60Yrs)
6.446800E-01
Normal-vs-Age(61-80Yrs)
7.479600E-01
Normal-vs-Age(81-100Yrs)
4.312400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.220600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.212600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.204000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.749400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.737000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.796800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.668000E-01
Normal-vs-Daily Drinker
9.361900E-02
Normal-vs-Weekly Drinker
6.269000E-01
Normal-vs-Occasional Drinker
5.188200E-01
Normal-vs-Social Drinker
9.630000E-01
Non Drinker-vs-Daily Drinker
3.753700E-02
Non Drinker-vs-Weekly Drinker
7.409000E-01
Non Drinker-vs-Occasional Drinker
6.221600E-01
Non Drinker-vs-Social Drinker
5.422800E-01
Daily Drinker-vs-Weekly Drinker
1.487620E-01
Daily Drinker-vs-Occasional Drinker
1.230000E-01
Daily Drinker-vs-Social Drinker
6.068100E-02
Weekly Drinker-vs-Occasional Drinker
9.180400E-01
Weekly Drinker-vs-Social Drinker
4.464600E-01
Occasional Drinker-vs-Social Drinker
3.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.596100E-02
Normal-vs-Grade 2
1.580000E-01
Normal-vs-Grade 3
9.360100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.527500E-02
Grade 1-vs-Grade 3
1.484370E-01
Grade 1-vs-Grade 4
9.596100E-02
Grade 2-vs-Grade 3
7.905400E-01
Grade 2-vs-Grade 4
1.580000E-01
Grade 3-vs-Grade 4
9.360100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.582000E-01
Normal-vs-NonDiabetic
5.557400E-01
Diabetic-vs-NonDiabetic
5.843600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.700600E-01
Normal-vs-NoPancreatitis
6.813600E-01
Pancreatitis-vs-NoPancreatitis
9.305000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.489400E-01
Normal-vs-N1
7.253000E-01
N0-vs-N1
9.611600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.024000E-01
Normal-vs-TP53-NonMutant
8.921400E-01
TP53-Mutant-vs-TP53-NonMutant
4.296800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
